Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12614000262606Phase 4Recruiting
Phase 4, open-label trial of bupivacaine and morphine in postoperative pain (3 arms), sponsored by Shahid Adeel. Primary endpoint: Total morphine consumption in the first 24 hours. Started Jun 2013; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12614000262606.